This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of biologically active molecules. Its unique spirocyclic structure makes it valuable for designing inhibitors targeting specific enzymes or receptors, particularly in the development of central nervous system (CNS) drugs. Researchers leverage its framework to enhance binding affinity and selectivity in drug candidates. Additionally, it is employed in the preparation of novel compounds for studying neurological disorders, such as Parkinson's disease and depression, due to its potential to modulate neurotransmitter systems. Its application extends to medicinal chemistry, where it aids in the exploration of new therapeutic agents with improved pharmacokinetic properties.